Scholarly Index
William Jacot
Institut de Recherche en Cancérologie de Montpellier; 16,665 total citations; 416 total publications; best world rank #37
Institut de Recherche en Cancérologie de Montpellier
16,665Total citations
416Total publications
50H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Advanced Breast Cancer Therapies | Lifetime | 210 | FR 13 | 98.26 |
| HER2/EGFR in Cancer Research | Lifetime | 490 | FR 24 | 97.97 |
| Cancer Treatment and Pharmacology | Lifetime | 876 | FR 64 | 97.70 |
| Cancer Cells and Metastasis | Lifetime | 980 | FR 31 | 96.36 |
| Brain Metastases and Treatment | Lifetime | 574 | FR 27 | 96.51 |
| Cancer Cells and Metastasis | 2021-2025 | 37 | FR 2 | 97.78 |
| Breast Cancer Treatment Studies | 2021-2025 | 81 | FR 6 | 98.88 |
| Advanced Breast Cancer Therapies | 2021-2025 | 59 | FR 7 | 98.96 |
| HER2/EGFR in Cancer Research | 2021-2025 | 73 | FR 4 | 98.81 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 892 | FR 47 | 96.54 |
| Cancer Treatment and Pharmacology | 2021-2025 | 198 | FR 16 | 96.08 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 920 | FR 58 | 91.30 |
| PARP inhibition in cancer therapy | 2021-2025 | 403 | FR 27 | 88.66 |
| Brain Metastases and Treatment | 2021-2025 | 818 | FR 28 | 83.70 |
| Cancer-related Molecular Pathways | 2021-2025 | 729 | FR 17 | 75.51 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 412 | FR 9 | 73.36 |